Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018
- PMID: 33973399
- PMCID: PMC8178482
- DOI: 10.1002/cam4.3764
Breast cancer in Zimbabwe: patterns of care and correlates of adherence in a national referral hospital radiotherapy center cohort from 2014 to 2018
Abstract
Background: Breast cancer is the second most common cancer among women in Zimbabwe. Patients face socioeconomic barriers to accessing oncology care, including radiotherapy. We sought to understand patterns of care and adherence for women with breast cancer in sub-Saharan Africa (SSA) with radiotherapy access.
Methods: A retrospective cohort was created for women with breast cancer evaluated at the Parirenyatwa Hospital Radiotherapy and Oncology Center (RTC) from 2014 to 2018. Clinical data were collected to define patterns of care. Non-adherence was modeled as a binary outcome with different criteria for patients with localized versus metastatic disease.
Results: In total, 351 women presented with breast cancer with median age 51 at diagnosis (IQR: 43-61). Receptor status was missing for 71% (248). 199 (57%) had non-metastatic disease, and 152 (43%) had metastases. Of women with localized disease, 34% received post-mastectomy radiation. Of women with metastatic disease, 9.7% received radiotherapy. Metastatic disease and missing HIV status were associated with increased odds of study-defined non-adherence (aOR: 1.85, 95% CI: 1.05, 3.28; aOR: 2.13, 95% CI: 1.11, 4.05), while availability of ER/PR status was associated with lower odds of non-adherence (aOR: 0.18, 95% CI: 0.09, 0.36).
Conclusions: Radiotherapy is likely underutilized for women with breast cancer, even in a setting with public sector availability. Exploring patient-level factors that influence adherence to care may provide clinicians with better tools to support adherence and improve survival. Greater investment is needed in multidisciplinary, multimodality care for breast cancer in SSA.
Keywords: Breast cancer; adherence to care; global health; multidisciplinary team; radiation oncology; radiotherapy; resource-limited setting.
© 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors report no conflicts of interest related to this work.
Figures
Similar articles
-
Utilization and predictors of postmastectomy radiation receipt in an Oncology Center in Zimbabwe.Breast Cancer Res Treat. 2021 Oct;189(3):701-709. doi: 10.1007/s10549-021-06338-w. Epub 2021 Aug 13. Breast Cancer Res Treat. 2021. PMID: 34387794
-
Patterns of Palliative Radiotherapy Utilization for Patients With Metastatic Breast Cancer in Harare, Zimbabwe.JCO Glob Oncol. 2021 Jul;7:1212-1219. doi: 10.1200/GO.20.00656. JCO Glob Oncol. 2021. PMID: 34343013 Free PMC article.
-
Effect of travel distance and time to radiotherapy on likelihood of receiving mastectomy.Ann Surg Oncol. 2015 Apr;22(4):1095-101. doi: 10.1245/s10434-014-4093-8. Epub 2014 Sep 23. Ann Surg Oncol. 2015. PMID: 25245129 Free PMC article.
-
Ten-year outcome after combined modality therapy for inflammatory breast cancer.Int J Radiat Oncol Biol Phys. 2003 Apr 1;55(5):1200-8. doi: 10.1016/s0360-3016(02)04201-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 12654428 Review.
-
Adjuvant therapy for breast cancer.NIH Consens Statement. 2000 Nov 1-3;17(4):1-35. NIH Consens Statement. 2000. PMID: 11512506 Review.
Cited by
-
Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancer.Breast Cancer Res Treat. 2023 May;199(1):1-12. doi: 10.1007/s10549-023-06886-3. Epub 2023 Mar 3. Breast Cancer Res Treat. 2023. PMID: 36867282 Free PMC article.
-
Hypofractionation in Breast Cancer Radiotherapy Across World Bank Income Groups: Results of an International Survey.JCO Glob Oncol. 2023 Jan;9:e2200127. doi: 10.1200/GO.22.00127. JCO Glob Oncol. 2023. PMID: 36706350 Free PMC article.
-
High-value breast cancer care within resource limitations.Oncologist. 2024 Jul 5;29(7):e899-e909. doi: 10.1093/oncolo/oyae080. Oncologist. 2024. PMID: 38780115 Free PMC article. Review.
-
Pharmacogenetics and pharmacokinetics of tamoxifen in a Zimbabwean breast cancer cohort.Br J Clin Pharmacol. 2023 Oct;89(10):3209-3216. doi: 10.1111/bcp.15827. Epub 2023 Jun 26. Br J Clin Pharmacol. 2023. PMID: 37337448 Free PMC article.
-
Radiation Therapy for Breast Cancer in Africa.Adv Radiat Oncol. 2024 Mar 12;9(6):101488. doi: 10.1016/j.adro.2024.101488. eCollection 2024 Jun. Adv Radiat Oncol. 2024. PMID: 38681886 Free PMC article. Review.
References
-
- The International Agency for Research on Cancer . The Global Cancer Observatory. Published 2018. Accessed September 14, 2020. https://gco.iarc.fr/today/.
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394‐424. - PubMed
-
- Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low‐resource and middle‐resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011;12:387‐398. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials